Mini Rev Med Chem. 2009 Mar;9(3):395-400.

New approaches to target the androgen receptor and STAT3 for prostate cancer treatments.

Source

Department of Urology, Mayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905, USA.

Abstract

Prostate cancer (PCa) is a common cause of death in men and remains incurable in the androgen-refractory phase. Growing evidence has shown that the androgen receptor (AR) and signal transducers and activators of transcription 3 (STAT3) could be effective targets for androgen-refractory PCa therapy. Many strategies have been reported to inhibit the AR or STAT3 activities. In this review, we focus on the AR N-terminal domain and AR chaperones, as well as small molecule inhibitors to STAT3 with which we discuss some new approaches to target the AR and STAT3 as potential treatments for androgen-refractory PCa.

PMID:: 19275732; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Icon for Bentham Science Publishers Ltd.

Save items

Related citations in PubMed

Review Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer. [J Cell Biochem. 2006]
Review Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer.
Wang G, Sadar MD. J Cell Biochem. 2006 May 1; 98(1):36-53.
An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells. [Mol Cell Endocrinol. 2007]
An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells.
Aaronson DS, Muller M, Neves SR, Chung WC, Jayaram G, Iyengar R, Ram PT. Mol Cell Endocrinol. 2007 May 30; 270(1-2):50-6. Epub 2007 Feb 17.
Review Manipulation of androgens and alterations in the androgen receptor axis in prostate cancer. [Minerva Urol Nefrol. 2008]
Review Manipulation of androgens and alterations in the androgen receptor axis in prostate cancer.
Nguyen MM, Wang Z. Minerva Urol Nefrol. 2008 Mar; 60(1):15-29.
Review Drug insight: role of the androgen receptor in the development and progression of prostate cancer. [Nat Clin Pract Oncol. 2007]
Review Drug insight: role of the androgen receptor in the development and progression of prostate cancer.
Taplin ME. Nat Clin Pract Oncol. 2007 Apr; 4(4):236-44.
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. [Endocr Relat Cancer. 2009]
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
Malinowska K, Neuwirt H, Cavarretta IT, Bektic J, Steiner H, Dietrich H, Moser PL, Fuchs D, Hobisch A, Culig Z. Endocr Relat Cancer. 2009 Mar; 16(1):155-69. Epub 2008 Nov 14.

See reviews... See all...

Cited by 2 PubMed Central articles

Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth. [World J Gastroenterol. 2011]
Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth.
Huang C, Yang G, Jiang T, Cao J, Huang KJ, Qiu ZJ. World J Gastroenterol. 2011 Jul 7; 17(25):2992-3001.
A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. [Am J Pathol. 2010]
A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.
Deng L, Zhou JF, Sellers RS, Li JF, Nguyen AV, Wang Y, Orlofsky A, Liu Q, Hume DA, Pollard JW, et al. Am J Pathol. 2010 Feb; 176(2):952-67. Epub 2009 Dec 30.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

New approaches to target the androgen receptor and STAT3 for prostate cancer tre...
New approaches to target the androgen receptor and STAT3 for prostate cancer treatments.
Mini Rev Med Chem. 2009 Mar ;9(3):395-400.

PubMed
Sexuality of women with anorexia nervosa.
Sexuality of women with anorexia nervosa.
Acta Psychiatr Scand. 1991 Jul ;84(1):9-11.

PubMed
Drug targets in cytomegalovirus infection.
Drug targets in cytomegalovirus infection.
Infect Disord Drug Targets. 2009 Apr ;9(2):201-22.

PubMed
TNF-alpha in tuberculosis: a cytokine with a split personality.
TNF-alpha in tuberculosis: a cytokine with a split personality.
Inflamm Allergy Drug Targets. 2009 Mar ;8(1):53-62.

PubMed
Personality disorders 2-5 years after treatment: a prospective follow-up study.
Personality disorders 2-5 years after treatment: a prospective follow-up study.
Acta Psychiatr Scand. 1991 Jul ;84(1):72-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

New approaches to target the androgen receptor and STAT3 for prostate cancer treatments.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information